PREVENTION OF OSTEOPOROSIS AFTER CARDIAC TRANSPLANTATION: A Prospective, Longitudinal, Randomized, Double-Blind Trial with Calcitriol1
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Accelerated bone loss is a well-recognized complication after cardiac transplantation (HTx) due to immunosuppressive therapy. The purpose of this prospective, longitudinal, randomized, placebo-controlled, double-blind study was to investigate the effect of calcitriol (1,25-dihydroxyvitamin D3) in the prevention of bone loss and fracture rate after HTx. METHODS: Basic therapy included 1000 mg of calcium daily and sex hormone replacement in hypogonadal patients. A total of 132 patients (111 male, 21 female; mean age: 51+/-10 years; 35+/-25 months after HTx) were randomized to 0.25 microg of calcitriol or placebo. Bone mineral density (BMD, g/cm2; T score, %) of the lumbar spine and x-rays for the assessment of vertebral fractures were performed at baseline and after 12, 24, and 36 months. Biochemical indexes of mineral metabolism were measured every 3 months. RESULTS: Overall BMD was significantly decreased after HTx (T score 87+/-13%). BMD increased continuously within the study period in the calcitriol group (1 year: 2.2+/-4.8%; 2 years: 3.9+/-5.4%; 3 years: 5.7+/-4.4%) as well as in the placebo group (1 year: 1.8+/-4.9%; 2 years: 3.7+/-6.5%; 3 years: 6.1+/-7.8%) without statistical difference between the groups. Fracture incidence was low during the study interval (1 year: 2.0%; 2 years: 3.4%; 3 years: 0%). Hypogonadism (20%) was associated with a lower BMD (78+/-12% vs. 88+/-12%; P<0.01) and a higher increase (35%) after hormone replacement in comparison to normogonadal patients. Increased intact parathyroid hormone and bone resorption markers decreased significantly during therapy. CONCLUSIONS: Calcium supplementation and sex hormone replacement in hypogonadism proved a sufficient long-term prevention therapy to improve decreased BMD and to prevent fractures after HTx. Besides immunosuppression, both concomitant hypogonadism and secondary hyperparathyroidism play a major role in the long-term bone loss and should therefore be monitored and treated adequately. Low-dose calcitriol demonstrated no significant extra benefit regarding BMD and fracture rate in the long-term period after HTx.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Professor Kanis, J. A., Melton, L. J., Christiansen, C., Johnston, C. C., & Khaltaev, N. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090802 · Cited by 3,849
Cited by
Vitamin D and Bone Health; Potential Mechanisms
Laird, E., Ward, M., McSorley, E., Strain, J. J., & Wallace, J. (2010) · Nutrients · doi:10.3390/nu2070693 · Cited by 358
Richy, F., Schacht, E., Bruyere, O., Ethgen, O., Gourlay, M., & Reginster, J.-Y. (2005) · Calcified Tissue International · doi:10.1007/s00223-004-0005-4 · Cited by 137
Richy, F., Ethgen, O., Bruyere, O., & Reginster, J.-Y. (2004) · Osteoporosis International · doi:10.1007/s00198-003-1570-5 · Cited by 136
Anastasilakis, A. D., Tsourdi, E., Makras, P., Polyzos, S. A., Meier, C., McCloskey, E. V., Pepe, J., & Zillikens, M. C. (2019) · Bone · doi:10.1016/j.bone.2019.07.006 · Cited by 71
Metadata
- Authors
- Stempfle, H.-U., Werner, C., Echtler, S., Wehr, U., Rambeck, W. A., Siebert, U., ??derfuhr, P., Angermann, C. E., Theisen, K., & G??rtner, R.
- Venue
- Transplantation
- Published
- 1999-08
- Volume
- 68
- Issue
- 4
- Pages
- 523-530
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W1964907392
- Cited by
- 78
- References
- 1
- FWCI
- 4.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PREVENTION OF OSTEOPOROSIS AFTER CARDIAC TRANSPLANTATION: A Prospective, Longitudinal, Randomized, Double-Blind Trial with Calcitriol1. https://app.cochat.ai/papers/10.1097/00007890-199908270-00014
- The paper
- Stempfle, H.-U., Werner, C., Echtler, S., Wehr, U., Rambeck, W. A., Siebert, U., ??derfuhr, P., Angermann, C. E., Theisen, K., & G??rtner, R. (1999). PREVENTION OF OSTEOPOROSIS AFTER CARDIAC TRANSPLANTATION: A Prospective, Longitudinal, Randomized, Double-Blind Trial with Calcitriol1. Transplantation. https://doi.org/10.1097/00007890-199908270-00014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.